Literature DB >> 10214696

Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases.

A V Kozyr1, A V Kolesnikov, E S Aleksandrova, L P Sashchenko, N V Gnuchev, P V Favorov, M A Kotelnikov, E I Iakhnina, I A Astsaturov, T B Prokaeva, Z S Alekberova, S V Suchkov, A G Gabibov.   

Abstract

DNA-hydrolyzing activity of IgG autoantibodies from sera of patients with various types of lymphoproliferative diseases was investigated. The association of DNA-hydrolyzing activity with the antibody (Ab) fraction has been proved by newly developed affinity-capture assay. Study of abzyme incidence in blood tumors and systemic lupus erythematosis (SLE) revealed linkage of anti-DNA Ab catalysts to mature B-cell tumors, and increased probability of DNA-abzymes formation on the background of autoimmune manifestations. These data suggest possible similarity between mechanisms of abzyme formation in SLE and B-cell lymphomas. A new mechanism of formation of DNA-specific catalytic Abs has been proposed based on the increased crossreactivity of polyclonal DNA-abzymes to DNA-depleted nuclear matrix proteins. The possibility of the abzyme production as Ab to the energetically destabilized ground state of the antigen has been discussed. Preliminary results were obtained that indicate the complement-independent cytotoxicity of anti-DNA autoantibodies isolated from blood of patients with SLE and chronic lymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10214696     DOI: 10.1007/bf02787708

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  24 in total

1.  Caspase-dependent cytotoxicity of anti-DNA autoantibodies.

Authors:  L P Sashchenko; S V Khaidukov; A V Kozyr; T I Luk'yanova; A G Gabibov; S V Suchkov; T V Bobik; Z S Alekberova; N V Gnuchev
Journal:  Dokl Biochem Biophys       Date:  2001 Sep-Oct       Impact factor: 0.788

Review 2.  Autoantibodies with enzymatic properties in human autoimmune diseases.

Authors:  Bharath Wootla; Sébastien Lacroix-Desmazes; Arthur E Warrington; Allan J Bieber; Srini V Kaveri; Moses Rodriguez
Journal:  J Autoimmun       Date:  2011-05-31       Impact factor: 7.094

3.  Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides.

Authors:  Alena V Kundzer; Margarita V Volkova; Dimitrios P Bogdanos; Stefan Rödiger; Peter Schierack; I Generalov; Georgy A Nevinsky; Dirk Roggenbuck
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 4.  Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases.

Authors:  G A Nevinsky; Valentina N Buneva
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

5.  Catalytic antibodies in patients with systemic lupus erythematosus.

Authors:  Vandana Pradhan; Pallavi Pandit; Prathamesh Surve; Maxime Lecerf; Anjali Rajadhyaksha; Milind Nadkar; Prasad V Khadilkar; Durga A Chougule; Aalaap A Naigaonkar; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Kanjaksha Ghosh; Srini V Kaveri
Journal:  Eur J Rheumatol       Date:  2018-08-07

6.  Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.

Authors:  Mirjana Pavlovic; Anna Kats; Michelle Cavallo; Ran Chen; James X Hartmann; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2010-07-20

7.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections.

Authors:  Taisiya A Parkhomenko; Elena S Odintsova; Valentina N Buneva; Elena V Kunder; Ivan V Zhyltsov; Sergey A Senkovich; Igor I Generalov; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2008-07-29       Impact factor: 5.310

8.  A Novel Method for Real-Time, Continuous, Fluorescence-Based Analysis of Anti-DNA Abzyme Activity in Systemic Lupus.

Authors:  Michelle F Cavallo; Anna M Kats; Ran Chen; James X Hartmann; Mirjana Pavlovic
Journal:  Autoimmune Dis       Date:  2012-12-05

9.  Multiple sites of the cleavage of 21- and 25-mer encephalytogenic oligopeptides corresponding to human myelin basic protein (MBP) by specific anti-MBP antibodies from patients with systemic lupus erythematosus.

Authors:  Anna M Timofeeva; Pavel S Dmitrenok; Ludmila P Konenkova; Valentina N Buneva; Georgy A Nevinsky
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

10.  Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis.

Authors:  Galina A Legostaeva; Dar'ya I Polosukhina; Anna M Bezuglova; Boris M Doronin; Valentina N Buneva; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2009-03-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.